ARCHIVES

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Rogers Reaffirms Congress’ Interest In Cancer Program; Act Renewal To “Broaden, Sustain It”

April 14, 1978

NCI Unveils Checklist for Omics Studies

February 7, 2013

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993

In Brief: Moorehead Heads ACCC; Anderson President Elect; Segaloff Dies; RAAD Cleveland Clinic Director

March 22, 1985

NCI Cooperative Group, Cancer Center Trials Listed

January 25, 2008

Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”.

February 15, 2002